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Abstract
T cell receptors (TCRs) pair in millions of combinations to create complex and personally unique
T cell repertoires. Using tetramers to analyze CD1b-reactive TCRs, we detected T cells with
highly stereotyped TCR α chains present among genetically unrelated tuberculosis patients. These
germline-encoded mycolyl-reactive (GEM) T cells were defined by CD4 expression and
rearrangement of TRAV1-2 to TRAJ9 with few N-region additions. TCR analysis by high
throughput sequencing, binding and crystallography showed linkage of TCR α sequence motifs to
high affinity antigen recognition. Thus, the CD1-reactive TCR repertoire is composed of at least
two compartments, high affinity GEM TCRs and more diverse TCRs with low affinity for CD1b-
lipid complexes. These data demonstrate high inter-donor conservation of TCRs, which likely
results from selection by a non-polymorphic antigen presenting molecule and an immunodominant
antigen.
Studies of T cells in vaccines, autoimmunity and infection rely on the model that highly
diverse TCRs recognize peptides bound to major histocompatibility complex (MHC)
proteins. However, lipids presented by CD1 proteins expand the biochemical range of
antigens for T cells 1. T cells recognize foreign lipid antigens from major pathogens like
Mycobacterium tuberculosis, indicating that microbial lipid recognition occurs during the
natural history of infectious diseases. Also, because CD1 and MHC proteins differ greatly in
their rates of polymorphism in human populations, comparison of MHC and CD1-reactive
TCRs provides an experimental system to study the role of host genetics in shaping human
TCR repertoires. Currently, understanding of the complexity of the overall T cell repertoire
is dominated by knowledge of MHC-restricted T cells, which form highly complex patterns
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based on pairing of rearranged TCR α and β chains that generate a unique TCR repertoire
for each person. This diversity is generated through variable (V), diversity (D) and joining
(J) segments, deletions and N-region additions. MHC class I and II proteins show
corresponding complexity, as they are highly polymorphic in human populations, and any
given protein sequence encoded at HLA-A, B, C, DR, DP, DQ loci can bind many peptides.
In contrast, CD1 polymorphisms are rare and are usually functionally silent 2. Thus, genetic
polymorphism, which represents one major driver of MHC-reactive TCR repertoire
diversity, is largely absent in the human CD1 system. To some extent, the non-polymorphic
nature of CD1 antigen presenting molecules plays out as an apparently simplified TCR
repertoire. The main example is invariant natural killer T cells (iNKT cells), which express
TRAV10 and TRAJ18 (previously known as Vα24 and Jα18) and are found in most human
donors 3, 4. However, most CD1-reactive T cells do not express this receptor. Other CD1d-
reactive T cells (diverse NKT cells) 5, 6 and all known T cells recognizing CD1a, CD1b or
CD1c utilize differing TCR V, D or J segments 7-10. Accordingly, ‘consensus’
classifications of the CD1 repertoire recognize three T cell types: iNKT cells, diverse NKT
cells and diverse T cells recognizing CD1a, CD1b and CD1c 11.
CD1a, CD1b and CD1c, known as the group 1 CD1 proteins, are broadly retained during
mammalian evolution 12, and they activate large numbers of T cells present in the blood and
tissues of humans 8, 9. However, information about their biology and TCR diversity is
extremely limited because no specific surface markers are known, and efficient methods to
capture clones for TCR sequencing have not been developed. Taking advantage of CD1b
tetramers as a new tool to study T cells in larger numbers, we identified highly stereotyped
TCRs comprised of nearly identical TCR α chains. These TCR amino acid sequences derive
from differing nucleotide sequences, showing that conserved TCRs arise through distinct
rearrangement events within individual donors. Further, such TCRs are expressed on cell
populations that are readily detectable among genetically unrelated donors ex vivo. These
finding identify a previously unknown type of TCR-conserved αβ T cell type and point to
inter-donor conservation of CD1b-reactive T cell responses.
RESULTS
T cells with high and low avidity for CD1b
To study lipid-reactive T cells in a disease setting, we used lipid extracts of Mycobacterium
tuberculosis to activate T cells from tuberculosis patients (Supplementary Fig. 1). By
screening a panel of clones for responses to mycobacterial lipids and CD1b, we detected
clone 18 (Fig. 1a). We identified the stimulating antigen as free mycolic acid (MA) (Fig.
1b), an essential long-chain mycobacterial lipid (Supplementary Fig. 2). Comparing its TCR
α and β chains to five previously known TCRs that recognize mycolyl lipids, we did not
observe conservation of TCR sequence or V or J gene segment usage (Table 1) 1, 7, 13-16.
Thus, initial results based on conventional cloning methods supported the widespread view
that TCRs in the group 1 CD1 system are diverse, similar to those of MHC-restricted T
cells 7, 8, 10, 17 and different from iNKT and mucosal-associated invariant T (MAIT) cells,
which express highly conserved TCRs 17, 18.
However, existing data 7, 8, 10 might inadequately represent the CD1b repertoire based on
the small numbers of clones harvested to date and the need to extensively culture such
clones to expand them. To bypass these problems and analyze T cells in the ex vivo setting
among patients immunized by natural infection, we generated CD1b tetramers 19 and loaded
them with glucose monomycolate (GMM; Supplementary Fig. 2). This mycobacterial
glycolipid antigen is produced in vivo during infection 20 and potently activates CD1b-
reactive T cells in humans and cows 15, 19, 21, 22. We sorted Tet+ T cells from three
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tuberculosis patients, cloned them at limiting dilution and screened for GMM-dependent
functional response. Whereas Clone 18 and other T cell clones in the group 1 CD1 system
were collected over many years (Table 1), tetramer binding to CD1b-reactive TCRs
efficiently enriched for the relevant CD1b-reactive T cells, yielding multiple mycolyl lipid-
reactive TCRs in all three patients studied (Fig. 2a). Thus, tetramer sorting represents an
efficient method to sample the natural CD1b-GMM-reactive T cell repertoire ex vivo,
demonstrating the existence of mycolyl lipid reactive clones among genetically unrelated
donors.
In all cases, clones that produced IFN-γ after GMM a ntigen stimulation also stained with
GMM-loaded CD1b tetramers (Fig. 2). Based on staining intensity, the analyzed clones
segregated into two groups detected with intermediate (Tetint) or high (Tethigh) staining.
Tetint clones (clones 2, 26, 34, 71) showed diverse patterns of CD4 and CD8 expression,
similar to clones generated by conventional methods (Table 1). In contrast, clone 18 and all
Tethigh clones (clones 1, 21, 42) expressed CD4 but not CD8 (Fig. 2a and Fig. 3a). Both
Tetint and Tethigh cells were isolated from each patient, suggesting that the differing avidity
patterns were not patient-specific, but instead existed as distinct cell types present side by
side in individual patients.
GMM-specific T cells have antimicrobial effector functions
To gain insight into helper or effector functions of CD1b-reactive T cells we used a
multiplex cytokine array to broadly profile cytokines produced by clones recognizing CD1b
(1,2, 26, 34, 42) or control clones generated in the same way (101 and 50) (Fig. 2b). Our
array design emphasized cytokines with defining roles in T helper cell function (TH1, TH17,
TH2), such as interferon-γ (IFN-γ), IL-17 and IL-13. We also tested whether T cells produce
two cytokines that are necessary for effective human anti-tubercular responses in vivo, TNF
and IFN-γ 23, 24. In all cases, short-term T cell cultures produced IFN-γ and TNF, while
helper cytokines like IL-2 and IL-17 were not consistently detected, suggesting an anti-
microbial function of GMM-specific T cells 23, 24. As observed previously with clones
cultured long-term in vitro 25, 26, these ex vivo studies confirmed that IFN-γ and TNF were
reliably produced.
GEM T cell clones express invariant TCR α chains
Similar to clones generated by conventional methods (Table 1), Tetint clones showed
differing TCR α genes. In contrast, all Tethigh clones expressed TCRs that were highly
similar to one another and the TCR expressed by clone 18 (Fig. 3a). The TCR α chains of
the Tethigh clones were identical in length and used the same variable (TRAV1-2) and
joining (TRAJ9) segments, with few N region additions, yielding the CDR3 consensus
sequence CAVRNTGGFKTIF (Fig. 3a). Because these similar rearrangements yielded
largely germline-encoded TCR α chains and mediate recognition of mycolyl lipids, we
designated these clones germline-encoded mycolyl lipid-reactive (GEM) T cells. Although
lacking strict sequence conservation, TCR β chains were apparently biased in variable
region (TRBV) usage. TRBV6-2 and TRBV30 are expressed in 3.6 % and 1 % percent of
human T cells 27, 28, yet were found in all of the original set of GEM clones (Fig. 2a and
Fig. 3). In addition to these clones from patients A22, C58, C52 and A14, single cell
sequencing of Tet+ cells from patients C40, C52, C58 returned three TRBV6-2, but no
TRBV30 sequences (Supplementary Fig. 3). Thus, GEM T cells are characterized by nearly
invariant TCR α chains and a TCR β variable region gene bias, a pattern similar to iNKT
cells and MAIT cells (Fig. 3b).
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GEM TCRs bind CD1b-GMM with high affinity
Because strict TCR α conservation was seen only among Tethigh clones, we hypothesized
that high-affinity binding of GEM TCRs to CD1b-GMM mediates the expansion of GEM T
cells 19. Binding of any TCR to CD1b had not been previously measured, so we developed a
plasmon resonance assay for binding of transmembrane region-truncated, disulfide-
linked 29. GEM TCRs to CD1b-GMM complexes. All three GEM TCRs showed
dissociation constants (KD) near to the value of ~ 1 μM (Fig. 4). These values are at the high
end of the range for TCRs recognizing natural peptide or lipid antigens, and they are
comparable to measurements of human NKT TCRs binding to the superagonist α-
galactosylceramide in complex with CD1d30. Thus, the bright staining by CD1b tetramers
for GEM clones (Fig. 2a) is explained by high affinity ternary interactions of αβ TCR
heterodimers with CD1b-GMM complexes.
GEM TCRs mediate antigen recognition
Next we determined the role of GEM TCRs in T cell activation by transferring TCRs into
TCR β deficient JRT3-T3.5 cells. Untransfected cells were not activated by antigens,
whereas expression of native GMM-reactive α and β TCRs (clones 42, 21, 1) in JRT3-T3.5
cells conferred specific recognition of GMM, but not MA, in all cases. TCR α and β chains
from the MA-specific clone 18 reconstituted MA, but not GMM recognition (Fig. 5a). Thus,
GEM TCRs are necessary for antigen-mediated activation, and the particular TCRs
determine antigen fine specificity.
To formally evaluate the relative contribution of TCR α and β chains in antigen fine
specificity, we transfected native, but mismatched, TCR α and β pairs from clones 1, 18, 21
and 42 to create chimeric TCRs and measured responses to MA and GMM antigens. In all
cases, transfectants responded to antigen or anti-CD3 stimulation, suggesting that the
chimeric TCRs were expressed and signaled into cells. Because all GEM T cell clones use
nearly identical TCR α sequences (Fig. 5a), we tested if TCR α chains play a dominant role
in determining antigen specificity. Pairing of α chains from three GMM-recognizing TCRs
(clones 1, 21, 42) with the β chain from the MA-specific TCR (clone 18) reconstituted
recognition of MA, but not GMM, in all cases (Fig. 5b). Thus, the TCR β chain determined
the fine specificity for two homologous antigens.
Functional dominance of the β chain was unexpected, given that TCR α chains were more
conserved in structure among GEM T cells. A converse set of TCR chain swaps, in which
the α chain of clone 18 was paired with β chains from clones 1, 21 and 42, yielded three
TCR chimeras, which did not respond to MA or GMM (Fig. 5c). Based on retained anti-
CD3 response among transfectants, this result was not likely due to failure of transfection or
signalling, but instead resulted from lack of antigen recognition by chimeric receptors. Thus,
in contrast to preserved recognition of MA by chimeric TCRs (Fig. 5b), failure to recognize
GMM in all chimeras suggested that the GMM glycolipid recognition was a more stringent
interaction, dependent on both TCR chains. All four native TCR α chains (clones 1, 21, 42
and 18) are similar in sequence, but clone 18 differs only at position 107 from clone 42, with
leucine substituted for arginine (Fig. 5a). Thus, position 107 in the CDR3 α sequence is
crucial for determining MA antigen recognition.
GEM TCR structures identify a lateral push from the β chain
To address the structural basis of TCR α and β pairing and gain general insights into the
molecular basis of antigen specificity of GEM TCRs, we expressed TCRs from clone 18 and
42 and solved their crystal structures at 2.2 Å resolution (Fig. 6a-c and Supplementary Fig.
4). By superimposing these two GEM TCRs with a human MAIT TCR 31, we could
compare three TCRs that share TRAV1-2 use, but differentially recognize CD1b and MA,
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CD1b and GMM, or MR1 and ribityl-lumazine antigens 32 (Fig. 6d). Despite shared use of
TRAV1-2, the MAIT and GEM TCRs differ in other aspects of their β chain and CDR3α
conformations (Fig. 6d), which presumably mediate their non-cross-reactive recognition of
CD1b and MR1 31, 33. However, this comparison provided specific insights into GEM TCR
pairing that agreed with results from TCR swaps. Although similar in structure, the two
GEM TCRs showed notable differences at the CDR3α-CDR3β interface, which derived
from perturbations in the germline encoded CDR1α loop that arise mainly from the residue
at position 107 in TCR β (Fig. 6). Whereas arginine 107 in the CDR3β of the MA-specific
clone 18 packs against its CDR3α loop, the corresponding interaction is missing in the
GMM-reactive clone, resulting in greater mobility in its CDR3α loop (Fig. 6d). This
structural feature in the β chain, which likely determines MA versus GMM reactivity, is
located nearby to the important TCR α residue 107, identified in TCR chain swap
experiments (Fig. 6d). Thus, these structural data point to a specific mechanism for β chain
influence on fine specificity, whereby the β chain pushes laterally on the invariant α chain at
a defined point on the CDRα-CDRβ interface, analogous to fine-tuning NKT TCR
specificity 34.
GEM T cells expand in vivo
In vitro studies of clones identified key features of GEM T cells, such as high affinity
TRAV1-2 TCRs and production of antimicrobial cytokines in response to mycobacterial
lipids. To determine if GEM T cells are present in vivo and share these properties, we tested
fresh polyclonal T cells from blood bank donors or tuberculosis patients in three types of
experiments (Supplemental Fig. 1). We first used a monoclonal antibody that recognizes
TCR α chains with TRAV1-2 sequences 35 to sort fresh PBMC into four populations based
on TRAV1-2 and CD4 expression. CD1b- and GMM-reactive cells should fall in the
TRAV1-2+CD4+ gate, and the majority of MAIT cells are expected in the TRAV1-2+CD4-
gate 18, 33, 35. Both TRAV1-2- populations should contain lymphocytes that should be
CD1b-independent. TRAV1-2-CD4- cells from a blood bank donor (BB2) showed antigen-
independent IFN-γ responses, which might represent NK cell recognition of the MHC class
Ilow target cell. The TRAV1-2-CD4+ control populations from all donors failed to recognize
GMM. In two blood bank donors (BB12 and BB2) and one tuberculosis patient (C58), IFN-
γ ELISPOT showed that TRAV1-2+CD4+ populations were activated by GMM or MA in a
CD1b-dependent manner. Thus, the in vitro analysis of clones and ex vivo analysis of
polyclonal T cells both agree that TRAV1-2 and CD4 expression are markers for a subset of
cells in the repertoire that recognize CD1b and mycolyl lipids (Fig. 7a and Supplementary
Fig. 1).
Contrasts among GEM T cells, NKT cells and MAIT cells
Next we evaluated whether certain aspects of GEM T cell response initially observed in
vitro, might also occur using more physiological APCs and apply to the ex vivo state. GEM
T cell activation by CD1b transfection of transformed cells (Fig. 2 and Fig. 7a) also occurred
in autologous monocyte-derived dendritic cells, which more closely resemble the main cell
population to express CD1b in the periphery (Supplementary Fig. 5a). Similar to results
obtained with clones (Fig. 2b), polyclonal GEM T cell responses from patient C58 to GMM
lead to IFN-γ and TNF secretion when measured directly ex vivo (Supplementary Fig. 5b).
Like clones, fresh TRAV1-2+CD4+ T cell populations showed detectable reactivity to both
MA and GMM antigens, but they produced higher IFN-γ concentrations in response to
GMM, suggesting that GMM is the immunodominant antigen (Figs. 1, 7a).
Ex vivo analysis of GEM T cells from tuberculosis patients highlights differences among
GEM T cells, NKT cells and MAIT cells. NKT cells were discovered and named in part
based on their expression of CD161 and other NK markers 11, and almost all MAIT cells
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express CD161 35. However, analysis of fresh CD1b Tethigh cells in three donors showed
varying rates of CD161 expression, with two donors expressing this marker at low
frequency, similar to that of total CD3+ cells (Supplementary Fig. 6a). NKT cells circulate in
a pre-activated state and typically express the activation marker CD69 36. Prolonged T cell
activation by antigens might additionally lead to the expression of the T cell exhaustion
marker PD1 37. However, CD69 and PD1 were not expressed above background levels by
Tethigh T cells in tuberculosis patients (Supplementary Fig. 6b-c). Overall, CD4 is a defining
marker of GEM T cells that can further distinguish GEM T cells from most TRAV1-2+CD4-
MAIT cells 18. CD69, CD161 or PD1 do not specifically mark GEM T cell populations ex
vivo.
TCR sequence conservation is linked to high avidity
CD1b-reactive clones with diverse TRAV1-2- TCRs or conserved TRAV1-2+ TCRs
segregate into Tetint and Tethigh cells, respectively. Both clone types were present in each
patient tested. This pattern suggested that GEM T cells and lower affinity CD1b-restricted T
cells might exist within the same repertoire of any patient. Polyclonal T cell analysis of
patient C58 yielded a broad range of tetramer staining intensity, extending from low to very
high absolute signal (Fig. 7b). Further, this pattern of varying tetramer staining intensity was
detected among other tuberculosis patients (C12, C32, C60 A14, A21, A22) (Supplementary
Fig. 6). Next, we directly tested the relationship between tetramer staining intensity and
TRAV1-2 expression. Fresh CD3+ T cells were analyzed for TRAV1-2+ T cell frequency
within Tetneg, Tetint and Tethigh T cell populations. Whereas anti-TRAV1-2 stains 1.8 % of
T cells and 3.6 % of Tetint cells, TRAV1-2 was expressed on 71 % of Tethigh cells (Fig. 7b).
Thus, polyclonal T cells showed clear linkage of TRAV1-2 TCR expression with high-
avidity binding to CD1b-GMM and indicated that GEM TCRs can dominate the high avidity
repertoire.
GEM T cells clonally expand in vivo
We sought to detect GEM T cells in a tetramer-independent manner by PCR. TRAV1-2 is
joined to TRAJ9 in all GEM clones, but TRAV1-2 is expressed in concert with other joining
regions in MAIT cells and MHC-restricted T cells. We designed primers for TCR constant
regions as a normalization control and primers that bind on both sides of the TRAV1-2–
TRAJ9 junction. Standard PCR detected the GEM defining junction in Tet+, but not Tet− T
cells from two tuberculosis patients (C58, A14) (Fig. 7c). Sequencing of the amplified
rearrangements yielded new TCR α chain sequences that fit the TCR α sequence motif for
GEM T cells (Fig. 3a). For example, rearrangements amplified from patient A14 contained a
TCR α chain sequence identical to clone 1, which was also derived from patient A14, and
two unique genetic rearrangements with 0 or 3 N nucleotides (Fig. 3a). Also, the
rearrangements amplified from patient C58 were identical to the TCR α chain of clone 42,
which was also derived from this subject. Furthermore, the same TCR α and β chain were
identified more than once during single cell sequencing experiments (Supplementary Fig. 3).
Isolation of identical TCR sequences from independent experiments using different blood
samples from the same subject strongly suggests expansion of GEM clones in vivo.
GEM T cells exist in the naïve repertoire
Mycolyl lipids are foreign mycobacterial antigens that drive expansion of antigen-specific T
cells during infection 16, 21, 22, 38, 39. After detecting GEM T cells in tuberculosis patients 19,
we sought to determine if they also exist in the naïve repertoire. Sorted TRAV1-2+CD4+ T
cells from two blood bank donors (BB2 and BB12) yielded detectable GMM- and CD1b-
dependent responses (Fig. 7a, Supplementary Fig. 1). Based on this initial result, we
quantitatively analyzed GEM-defining TCR sequences using real-time PCR (RT-PCR) and
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high-throughput sequencing. RT-PCRon TRAV1-2+CD4+ sorted cells from two blood bank
donors, BB36 and BB38, and four tuberculosis patients (C28, C34, C52, C58) detected the
TRAV1-2–TRAJ9 junction in all subjects tested but signals were significantly higher among
the tuberculosis patients (Fig. 7d). These findings are consistent with the presence of a small
GEM T cell population in the naive repertoire and expansion after tuberculosis infection.
However, not every possible TRAV1-2–TRAJ9 junction corresponds to a GEM T cell
sequence. To determine if the candidate GEM TCR α chains detected in blood bank donors
actually met the length and sequence criteria for GEM T cells, we performed deep
sequencing of the TCR α chains of the sorted TRAV1-2+CD4+ cells from donors BB36 and
BB38 (Fig. 7d, Supplementary Fig. 7). Among 7,282 (BB36) and 6,861 (BB38) productive
TRAV1-2 sequences analyzed, 0.48 % and 0.90 % encoded CAVRXTGGFKTIF or
CAVLXTGGFKTIF, where X is any amino acid (Fig. 3, Supplementary Fig. 7). All eight
clones identified used limited N region additions. Although deep sequencing did not provide
information on the TCR β chain, the TCR α sequences proved that T cells bearing the
defining GEM TCR α motif could be detected at low frequencies in the bloodstream of
blood donors.
DISCUSSION
These data identify GEM T cells as one of three known TCR-conserved cell types in
humans. GEM T cells, iNKT cells and MAIT cells show strict TCR α sequence
conservation with biased selection of TCR β chains. Further, GEM T cells and MAIT cells
are defined by the same TCR a variable region gene. TRAV1-2 is located at the most
upstream position in the TRA-TRD locus, suggesting possibly shared mechanisms of TCR
rearrangement or target binding to CD1b and MR1. However, clear differences in TCR
structure and phenotype distinguish these three cell types. These data show that GEM T cells
differ from MAIT cells in their CD4 expression, J segment usage, antigen binding surfaces
and antigen specificity 18, 33. Contrasting with iNKT cells, GEM T cells have apparently
lower baseline autoreactivity, lower precursor frequencies in the blood, low CD69
expression, suggesting that they are more dependent on infection to drive expansion 19.
CD1b and CD1d differ in expression in the periphery, with CD1b expression largely
restricted to DCs versus broad expression of CD1d on gastrointestinal epithelia,
macrophages and B cells 40. Whereas iNKT cells are preactivated by self antigens and have
a patrolling functions mediated by autoreactivity, these features point to a role for GEM T
cells in the host response to infection.
We propose a model of the CD1b repertoire with at least two compartments: high affinity
conserved TCRs and low affinity diverse TCRs. Because high affinity antigen recognition is
linked to invariant TCR sequences, multiple TRAV1-2/TRAJ9 rearrangements create TCRs
that likely drive expansion of GEM T cells through high affinity interactions with CD1b-
lipid. Amino acid and nucleotide patterns suggest two mechanisms of expansion. First,
identical TCR α and β chain nucleotide sequences were derived from different blood
samples or culture wells from the same donors, suggesting that GEM T cells undergo clonal
expansion in vivo prior to phlebotomy. Second, most sequences are distinct in ways that
prove that GEM T cell populations in the blood derive from many independent TCR
arrangement events. For example, three rearrangements with differing underlying nucleotide
sequences give rise to identical CDR3 α amino acid sequences in donor BB36. Also, highly
similar CDR3 α amino acid sequences in clones 1, 18, 21 and 42 derive from differing
patterns of exonucleolytic trimming of the V and J regions. Autoreactivity to CD1b was not
observed, and any self antigen that could support the thymic selection of GEM T cells is
unknown. Therefore, the basis for emergence of GEM T cells among donors without known
mycobacterial infection remains unexplained. However, it is possible that environmental or
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self antigens cause GEM T cell expansion in a way that is comparable to the recently
described MHC-restricted, HIV-specific T cells in unexposed donors 41.
Current views emphasizing the diversity of group 1 CD1-reactive TCRs derive from small
panels of T cell clones 7-10. We initially viewed clone 18 as further evidence of TCR
diversity in the CD1b repertoire, but it was actually the prototype for a larger T cell
population cells later identified in many unrelated donors. Based on reliability of higher
throughput tetramer methods and the non-polymorphic nature of human CD1 molecules, we
predict that inter-donor TCR conservation in the CD1 repertoire is more common than is
currently appreciated. This hypothesis can be addressed through analysis of many clones
using newly generated of human CD1a, CD1b 19 and CD1c 42 tetramers.
Inter-donor CDR3 diversity is the dominant pattern for MHC-restricted TCRs, with the
notable exception of public TCRs detected in donors that share an MHC allele and specific
antigenic exposure 43. The GEM TCR could be considered a kind of public TCR that
recognizes CD1b. CD1b is expressed in an identical form in essentially all humans, which is
not the case for even the most common MHC allele. In the MHC system, public TCRs are
proposed to arise via convergent recombination, a process whereby multiple recombination
events with few N nucleotide additions produce differing nucleotide sequences that encode
the same amino acid sequence 44. GEM TCR α chain sequences display these hallmarks.
Inter-donor TCR conservation might be of practical use in tracking of CD1-restricted T cells
or possibly TCR-based immunodiagnosis. In the MHC system, particular TCR sequences do
not normally predict the antigens recognized by genetically unrelated donors. Even the
conserved iNKT TCR does not correspond to any single antigen of known biological
function. Here we show that the GEM TCR α chain sequence is associated with recognition
of lipids produced by a defined genus of pathogenic bacteria. Thus, CD1b tetramers, PCR
primers or monoclonal antibodies for the GEM TCR α chain might now be evaluated as
TCR-based tests for tuberculosis. GEM T cells are a plausible target for vaccination with
mycobacterial lipids.
METHODS
Antigens
C32 GMM was purified from R. equi and C80 GMM was purified from M. phlei as
described 20. MA was obtained from Sigma. M. tuberculosis lipid extract was prepared by
extracting a pellet of 7H9 grown H37Rv with choroform/methanol 1:2 (V:V) for two hours
at room temperature, followed by chloroform/methanol 2:1. Glycerol monomycolate was
purified from lipid extract from M. bovis BCG grown in Sauton’smedium, followed by
loading on a silica column and elution with chloroform.
Flow cytometry
CD1b monomers (NIH tetramer facility) were loaded with R. equi-derived GMM and
assembled into tetramers 19. Tetramers were incubated for 30 minutes at room temperature
prior to adding monoclonal antibodies for an additional 30 minutes on ice. Flow cytometry
data were pre-gated for lymphocytes based on forward and side scatter. Antibodies are
detailed in Table 1 Cells were sorted on an 11-color FACSAria (Becton Dickinson).
T cell cloning and T cell assays
Blood was obtained after informed consent from asymptomatic tuberculin positive subjects
clinically assessed to have latent tuberculosis but with no clinical or radiographic evidence
of active tuberculosis, from a patient with smear-positive pulmonary tuberculosis, and from
blood bank donors, as approved by the institutional review boards of the Lemuel Shattuck
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Hospital and Partners Healthcare. Sorted GMM-loaded Tet+19 T cells were stored overnight
in medium containing 0.2 ng/ml IL-15 and plated the next day at 1 cells/well in round
bottom 96-well plates containing 2 ×105 irradiated allogeneic peripheral blood mononuclear
cells, 4 ×104 irradiated Epstein-Barr virus transformed B cells, 30 ng/ml anti CD3 antibody
OKT3 and 1 ng/ml of IL-2 which was added on day 2 of the culture. Alternatively, PBMC
were stimulated with autologous monocyte-derived DC and 1 μg/ml total lipid extract of M.
tuberculosis, and IFN-γ secreting cells isolated (Miltenyi Biotech) and cloned. After 3
weeks, the wells with visible growth were restimulated. Clones were tested for binding of
GMM loaded tetramer by flow cytometry and for antigen specificity in an ELISPOT assay.
For ELISPOT assays, cocultures of APCs and T cell were incubated for 16 h in a
Multiscreen-IP filter plate (96 wells; Millipore) coated according to the manufacturer’s
instructions (Mabtech). Antibodies are detailed in the online methods.
PCR and molecular cloning
From expanding T cell clones and sorted T cell populations, RNA was isolated with an
RNeasy kit (Qiagen), and cDNA was synthesized with a Quantitect reverse transcription kit
(Qiagen), including a genomic DNA–removal step. V segment usage was determined by
PCR using primerset IPS000029 and IPS000030 as described at www.imgt.org in
combination with TCR α constant region reverse primer 5’
GTGGTAGCAGCTTTCACCTCCTTGG 3’ and TCR β constant region reverse primer 5’
GGTGGCAGACAGGACCCCTTGC 3’. Taq polymerase was used in the supplied buffer
(Denville) under the following cycling conditions: an initial denaturation of 5 min. at 95°C,
followed by 35 cycles of 1 min. at 94°C, 1 min. at 59°C, 1 min. at 72°C, followed by a final
elongation step of 7 min. at 72°C. For detection of TCRs using TRAJ9, a V segment specific
forward primer was used in combination with TRAJ9 reverse primer 5’
GGTTCTGGATATTTGCTTTAACAAATAG 3’. For the cloning of the full length TCR α
and β chains of clones 1, 18, 21, and 42 (Genbank accession numbers JQ778257-JQ778264)
the following primers were used: FL_TRAV1-2_For_NheI:
CTAGCTAGCGCAGCAGATGTGGGGAGTTTTCCTTC; FL_TRBV6-2_For_NotI:
CTAGCGGCCGCCCTGCCATGAGCCTCGGGC; FL_TRBV30_For_NotI:
CTAGCGGCCGCGGCTTGGATGATGCTCTGCTCTC; FL_TRAC_Rev_XhoI:
CAGCTCGAGCAATCTTAATCATAAATTCGGGTAGGATCCCATC;
FL_TRBC2_Rev_BamHI: TATGGATCCGGAGCTAGCCTCTGGAATCCTTTC. TCR α
and β chains were cloned into pREP7 and pREP9 vectors, electroporated into JRT3-T3.5
cells and grown in medium containing 1.5 mg/ml Geneticin (Gibco) and 0.5 mg/ml
hygromycin B (Invitrogen) for 4-6 weeks. Recognition of mycolyl lipids by transfectants
was tested in an IL-2 ELISPOT assay in the presence of monocyte derived dendritic cells
and 10 ng/ml phorbol 12-myristate 13-acetate.
Single cell sequencing
For single cell TCR sequencing cells were sorted in wells of a PCR plate containing 2.5 μl
cDNA synthesis reaction mix consisting of 0.1 % Triton X-100 (Sigma-Aldrich) and 0.2 μl
iScript reverse transcriptase in 1x iScript reaction buffer, and incubated 25°C for 5 minutes,
42°C for 30 minutes, and 85°C for 5 minutes. Subsequently, a pre-amplification targeting
TRAV1-2 and all TRBV segments was performed in GoTaq Flexi (Promega) reaction
mixture containing 2.5 mM MgCl, 0.2 mM each dNTP, 0.025 U/μl GoTaq polymerase, 0.14
μM each of 26 TRBV-specific forward primers, 0.25 μM of constant β reverse primer 5’
GGTGGCAGACAGGACCCCTTGC 3’, 0.125 μM of TRAV1-2 specific forward primer 5’
GCAACATGCTGGCGAAGCACCCAC 3’, and 0.125 μM of constant α reverse primer 5’
GTGGTAGCAGCTTTCACCTCCTTGG 3’, under the following cycling conditions: an
initial denaturation of 2 min. at 95°C, followed by 25 cycles of 30 sec. at 95°C, 1 min. at
59°C, 1 min. at 72°C, followed by a final elongation step of 5 min. at 72°C. The pre-
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amplification mixture was diluted to a total volume of 75 μl, and 5 μl was used in a RT-PCR
reaction to determine TRAV1-2 message with 0.25 μM each of an internal TRAV1-2 primer
5’TCCTTAGTCGGTCTAAAGGGTACAG 3’ and internal constant α reverse primer
5’CATCAGAATCCTTACTTTGTGACACATTTG 3’using the Sybr green (BioRad)
method 18. The TRAV1-2 PCR product of positive wells was isolated and sequenced and
aliquots of the pre-amplified cDNA was amplified in individual PCR reactions with the V β
specific forward primers and the constant β reverse primer 5’
ACACAGCGACCTCGGGTGGG 3’. Positive reactions were detected by agarose gel
electrophoresis, and the amplicons were sequenced.
RT-qPCR, deep sequencing
Relative quantity of the TRAV1-2–TRAJ9 junction was determined relative to constant α
chain message using the TaqMan (Applied Biosystems) method using the following primers
and probes: TRAV1-2 forward primer: 5’TCCTTAGTCGGTCTAAAGGGTACAG 3’;
TRAJ9 reverse primer: 5’TTGCTTTAACAAATAGTCTTGTTCCTGCTCC 3’; TRAV1-2
probe: 5’ FAM-CTCCAGATGAAAGACTCTGCCTCTTACCTCTGTGC-BHQ 3’;
constant α forward primer: 5’CTGACCCTGCCGTGTACCAG 3’; constant α reverse
primer: 5’ CATCAGAATCCTTACTTTGTGACACATTTG 3’; constant α probe: 5’FAM-
CCAGTGACAAGTCTGTCTGCCTATTCACCGATTTTG-BHQ 3’. For deep sequencing
of TRAV1-2 α chains, V segment-specific linear amplification and next-generation
sequencing was performed as described previously 45, 46.
TCR affinity measurements
Soluble TCR proteins were expressed and purified as described 29 and floated in increasing
concentrations over GMM-loaded CD1b coupled to research-grade streptavidin-coated chips
in a Biacore 3000. The final response was calculated by subtraction of the response of the
unloaded CD1b. BIAevaluation version 3.1 software (Biacore AB) was used to fit the data
to the 1:1 Langmuir binding model and the equilibrium data were analyzed with the Prism
program for biostatistics, curve fitting and scientific graphing (GraphPad).
TCR crystallisation, data collection and structure determination
Clone42 TCR crystals were grown by the vapour-diffusion method at 20°C with a protein/
reservoir drop ratio 1:1 at a concentration 5mg/ml in 20 % PEG 3350, 0.05M Na-HEPES pH
7 and 1 % tryptone w/v. Clone18 TCR crystals were grown using the same technique with
25 % PEG1500 and 10 % Proprionate-cacodylate-bis tris propane pH7. TCR crystals were
soaked in a cryoprotectant solution containing mother liquor solution with the PEG
concentration increased to 25 % and then flash frozen in liquid nitrogen. Data were collected
on the Micro-focus beamline (MX2) at the Australian Synchrotron with an ADSC-Q315r
CCD detector at 100K. Data were processed as described previously 29 followed by
maximum-likelihood refinement with the Buster program 47. The structures were
determined by molecular replacement using the ELS4 TCR as model 48 with the PHSER
program. Manual building was conducted with the COOT software followed by maximum-
likelihood refinement with the Buster program. The final models were validated using the
Protein Data Base validation website, and the final refinement statistics are summarized in
Figure S4. The coordinates are available under the accession number: 4G8E for the clone18
TCR and 4G8F for the clone 42 TCR.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. CD1b-restricted T cell clones generated by conventional methods
(a) ELISPOT assay of IFN-γ production by clone 18 after stimulation with K562 cells
transfected with CD1a, CD1b, CD1c or CD1d in the presence or absence of M. tuberculosis
lipid extract. (b) ELISPOT assay of IFN-γ production by clone LDN5 and clone 18
stimulated with glucose monomycolate (GMM), mycolic acid (MA) or glycerol
monomycoalte (glycerol MM) and K562 cells transfected with CD1b. Panels a and b show
standard deviation of triplicate measurements and are representative of three experiments
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Figure 2. Tetramer-based approaches efficiently generate CD1b-restricted T cell clones
(a) Clones derived from PBMC of subjects A14, A22 and C58 were selected for staining
with GMM-loaded CD1b tetramers. CD1b dependence and GMM reactivity of the Tet+
clones was confirmed by stimulation with K562 cells transfected with CD1a, CD1b, CD1c,
or CD1d in the presence or absence of GMM. Tetramer staining was performed once on
each clone, and ELISPOT experiments were performed twice on each clone. The SD of
triplicate ELISPOT wells of one experiment is shown. (b) Supernatants of Tet+, GMM
reactive clones 1, 2, 26, 34, 42, and Tet−, GMM non-reactive control clones 101
(CD4+TRAV1-2+) and 50 (CD8+TRBV4-1+), stimulated with or without PMA and
ionomycin for 16 hours, were tested for cytokine content in a Luminex assay.
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Figure 3. Conserved TCRs and CD4 define germline-encoded mycolyl-reactive (GEM) T cells
(a) The CDR3 regions of CD1b-restricted GEM T cell clones are shown according to the
their origin. GEM TCR sequences are compared to sequences from a non-GEM T cell clone
recognizing CD1b (LDN5) and representative sequences from NKT (J3N.5) and MAIT cell
clones (TRBV20). Light grey: germline-encoded V segment derived nucleotides; Dark grey:
germline-encoded J segment derived nucleotides; Boxed: non-germline-encoded nucleotides
in the α chain. TRBV6-2 and TRBV6-3 containing transcripts cannot be distinguished
because the coding sequence of the two genes is identical. For simplicity, we refer to this
shared sequence as TRBV6-2. (b) Human TCR conserved T cells types are illustrated.
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Figure 4. GEM TCR affinity
(a) Surface plasmon resonance measurements of the interaction between soluble TCRs of
clones 1, 21 and 42 and immobilized CD1b-GMM complexes, and the equilibrium
dissociation constants calculated from these measurements. Error bars represent SEM of two
independent experiments.
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Figure 5. Antigen specificity of TCR transfectants
(a) JRT3-T3.5 cells were transfected with the α and β chains of the native TCRs of GEM
clones 18, 21, 1 and 42 and analysed for recognition of GMM and MA presented by
monocyte-derived dendritic cells. CDR3a sequences are shown on top with position 107 in
bold. (b) To form chimeric TCRs, the TCR α chain of clone 18 was combined with the β
chain of clones 21, 42, or 1 and (c) the α chains of clones 21, 42, or 1 were combined with
the β chain of clone 18. Function of TCR reconstituted cells was determined with antigen or
an activating α-CD3 (OKT3) antibody for cells refractory to antigen. The error bars
represent the SD of triplicate wells, and results are representative of two independent
transfection experiments.
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Figure 6. GEM TCR structures
Structures of the TCRs of clone 18 (a), 42 (b) and a human MAIT clone 31 (c), each with a
surface representation of the antigen binding face of the TCRs. Dashed lines represent
residues missing from pdb coordinates. Pink: TRAV1-2 α chains; grey: TRBV6-2 β chains;
green: TRBV20 β chain. (d) Overlay of CDR1-3α and CDR1-3β loops of GEM TCRs with
the MAIT TCR. The structural superimpositions were performed over the Vα regions of the
three TCRs. CDR loops of clone 18 (purple), clone 42 (blue) and the MAIT (green) TCRs
are shown.
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Figure 7. GEM T cells in polyclonal populations ex vivo
(a) Equal numbers of PBMC were sorted based on staining with antibodies against CD4 and
TRAV1-2 and tested using K562 cells transfected with CD1b and CD1c in the absence or
presence of GMM or MA. The experiment was performed twice in donors BB12 and BB2,
and three times in donor C58, with similar results. (b) PBMC of subject C58 were stained
with α-CD3, GMM-loaded CD1b tetramer and α-TRAV1-2. This experiment was
performed twice with similar results. (c) The cDNA of 4000 sorted Tet+ and Tet− cells was
used in a PCR with a TRAV1-2 and TRAJ9-specific primer pair. Cell sorting was performed
once, and PCR was performed twice for each donor. (d) Quantity of TRAV1-2–TRAJ9
junctions relative to constant α chain was determined in cDNA from sorted
CD4+TRAV1-2+ PBMC from blood bank donors and tuberculosis patients. Deep
sequencing of the TCR repertoire of BB36 and BB38 revealed that 0.48 % and 0.90 % of the
TRAV1-2+CD4+ T cells, or 0.0024 % and 0.0023 % of the total PBMC population,
respectively, expressed typical GEM α chains.
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Table 2
Antibodies used for cell sorting, flow cytometric analysis and T cell activation assays.
Target molecule Clone number Fluorophore/tag Manufacturer Application
IFN-γ 1-D1-K none Mabtech ELISPOT
IFN-γ 7-B6-1 biotin Mabtech ELISPOT
IL-2 IL-2-I/249 none Mabtech ELISPOT
IL-2 IL-2-II biotin Mabtech ELISPOT
TNF TNF3/4 none Mabtech ELISPOT
TNF TNF5 biotin Mabtech ELISPOT
CD3 SK7 FITC BD Bioscience Flow cytometry
CD3 OKT3 none In house T cell activation
CD1b BCD1b3.1 none In house Neutralization
Isotype IgG1 P3 none In house Neutralization
CD4 RPA-T4 APC BD Bioscience Flow cytometry
CD8α OKT8 none In house Flow cytometry
CD8β 2ST8.5H7 none Beckman Coulter Flow cytometry
TRAV1-2 3C10 PE Biolegend Flow cytometry
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